GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

Illumina Inc. closed $13.90 short of its 52-week high ($144.02), which the company achieved on January 31st.

After hours: September 26 at 7:19 PM EDT ...

The stock's rise snapped a four-day losing streak.

Illumina completed the deal just under a year later, bringing Grail back under its ownership, having previously spun the company out. Only three years after the arrangement was struck, Illumina ...

BRUSSELS (Reuters) -U.S. gene sequencing company Illumina on Tuesday won its court fight against the European Union's investigation of its $7.1 billion purchase of cancer diagnostic test maker ...

On Thursday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $132.27 which represents a slight increase of $6.12 or 4.85% from the prior close of $126.15. The stock opened at $128.04 ...

Illumina Inc (ILMN) stock saw a decline, ending the day at $128.82 which represents a decrease of $-1.28 or -0.98% from the prior close of $130.1. The stock opened at $130.49 and touched a low of $128 ...

Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Check the time stamp on this data. Updated AI-Generated Signals for Illumina Inc. (ILMN) available here: ILMN.